Healthcare & Medical Devices Global On demand · 24-48h

Global Premenstrual Syndrome Treatment Market Strategic Research Report

Global Premenstrual Syndrome Treatment Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Premenstrual Syndrome Treatment Market
$1.41B2025
3.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Medication, Dietary Treatment, Emotional Treatment, Hormone Therapy, Others

By Application: Younger than 20 Years, 20-40 Years Old Adults

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer, Shionogi, Johnson & Johnson, Novartis AG, Merck & Co., Inc., Allergan plc, Mylan N.V.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 102 pages
Market size 2025
$1.41B
Billion USD
Forecast CAGR
3.5%
2025-2032
Forecast 2032
$1.8B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Premenstrual Syndrome Treatment market size is predicted to grow from US$ 1,413 million in 2025 to US$ 1,793 million in 2032; it is expected to grow at a CAGR of 3.5% from 2026 to 2032.

Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.

The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.

The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:

Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.

Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.

Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.

Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.

Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.

Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.

Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.

Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.

The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:

Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.

Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.

Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.

Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.

Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.

Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.

Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.

Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.

This report presents a comprehensive overview of the global Premenstrual Syndrome Treatment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Medication
  • Dietary Treatment
  • Emotional Treatment
  • Hormone Therapy
  • Others

Segment by Application

  • Younger than 20 Years
  • 20-40 Years Old Adults

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Premenstrual Syndrome Treatment market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Younger than 20 Years, 20-40 Years Old Adults evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Premenstrual Syndrome Treatment Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.41B
2025
Forecast
$1.8B
2032
CAGR
3.5%
2025–2032
Régions
5
global
Key companies
AbbVieAstraZenecaBASF CorporationBayerEli Lilly And CompanyGlaxoSmithKlinePfizerShionogi
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
MedicationDietary TreatmentEmotional TreatmentHormone TherapyOthers
By Application
Younger than 20 Years20-40 Years Old Adults

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Medication
  • 3.1.3 Dietary Treatment
  • 3.1.4 Emotional Treatment
  • 3.1.5 Hormone Therapy
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Younger than 20 Years
  • 4.1.3 20-40 Years Old Adults
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 AbbVie
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 AstraZeneca
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BASF Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bayer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Eli Lilly And Company
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 GlaxoSmithKline
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Pfizer
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shionogi
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Johnson & Johnson
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Novartis AG
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Merck & Co., Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Allergan plc
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Mylan N.V.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Premenstrual Syndrome Treatment market?
The global Premenstrual Syndrome Treatment market is estimated at US$ 1.41 billion in 2025 (base year) and is projected to reach US$ 1.79 billion by 2032.
How fast is the Premenstrual Syndrome Treatment market expected to grow?
The market is expected to grow at a CAGR of 3.5% from 2026 to 2032, expanding from US$ 1.41 billion in 2025 to US$ 1.79 billion in 2032, roughly 1.3 times its base-year value.
What does the Premenstrual Syndrome Treatment market cover?
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
What are the main segments of the Premenstrual Syndrome Treatment market by type?
By type, the market is segmented into Medication, Dietary Treatment, Emotional Treatment, Hormone Therapy and Others.
Which applications drive demand in the Premenstrual Syndrome Treatment market?
Key applications covered include Younger than 20 Years and 20-40 Years Old Adults.
Who are the key players in the Premenstrual Syndrome Treatment market?
Key players profiled include AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer and Shionogi, among 13 companies covered in total.
Which regions and countries are covered for Premenstrual Syndrome Treatment?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Premenstrual Syndrome Treatment market?
This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Who should buy the Premenstrual Syndrome Treatment market report?
The report is intended for manufacturers and solution providers, distributors and end users in Younger than 20 Years and 20-40 Years Old Adults, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Premenstrual Syndrome Treatment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.